Research ArticleClinical Investigations
Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions
Esther I. van Vliet, John J. Hermans, Maria A. de Ridder, Jaap J. Teunissen, Boen L. Kam, Ronald R. de Krijger, Eric P. Krenning and Dik J. Kwekkeboom
Journal of Nuclear Medicine September 2012, 53 (9) 1359-1366; DOI: https://doi.org/10.2967/jnumed.112.102871
Esther I. van Vliet
1Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
John J. Hermans
2Department of Radiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Maria A. de Ridder
3Department of Biostatistics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; and
Jaap J. Teunissen
1Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Boen L. Kam
1Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Ronald R. de Krijger
4Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Eric P. Krenning
1Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Dik J. Kwekkeboom
1Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 9
September 1, 2012
Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions
Esther I. van Vliet, John J. Hermans, Maria A. de Ridder, Jaap J. Teunissen, Boen L. Kam, Ronald R. de Krijger, Eric P. Krenning, Dik J. Kwekkeboom
Journal of Nuclear Medicine Sep 2012, 53 (9) 1359-1366; DOI: 10.2967/jnumed.112.102871
Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions
Esther I. van Vliet, John J. Hermans, Maria A. de Ridder, Jaap J. Teunissen, Boen L. Kam, Ronald R. de Krijger, Eric P. Krenning, Dik J. Kwekkeboom
Journal of Nuclear Medicine Sep 2012, 53 (9) 1359-1366; DOI: 10.2967/jnumed.112.102871